Arbutus Biopharma History - Founding, Milestones & Growth Journey

History

Year	Detail
2005	The company Arbutus Biopharma was founded in Pennsylvania, U.S.
2012	Arbutus entered into a license agreement with Alnylam that entitles Alnylam to develop and commercialize products with our lipid nanoparticle (LNP) delivery technology.
2018	The company has entered into an agreement with Roivant Sciences Ltd. to launch Genevant Sciences Ltd. (Genevant), a company focused on a broad range of RNA-based therapeutics enabled by our LNP and ligand conjugate delivery technologies.
2021	Arbutus has entered into a technology transfer and license agreement with Qilu.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.